Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bergmann

Showing results (221-230 of 254) with videos related to

Pageof 26
Sort By:
Journal of Extracellular Biology|August 7, 2023
Retroviral b-Zip protein (HBZ) contributes to the release of soluble and exosomal immune checkpoint molecules in the context of neuroinflammationJulie Joseph, Thomas A Premeaux, Daniel O Pinto, et al.
Vaccine|January 12, 2021
Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS,S malaria vaccineSidhartha Chaudhury, Randall S MacGill, Angela M Early, et al.
Frontiers in Immunology|July 13, 2013
Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malariaElke S Bergmann-Leitner, Heather Hosie, Jessica Trichilo, et al.
Poultry Science|November 30, 2018
Investigation of the prevalence and severity of foot pad dermatitis at the slaughterhouse in fattening turkeys reared in organic production systems in GermanyD Freihold, T Bartels, S Bergmann, et al.
Vaccine|December 23, 2017
Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccineStephen A Kaba, Christopher P Karch, Labdhi Seth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2022
Susceptibility to Human Immunodeficiency Virus Type 1 Acquisition Linked to Malaria Exposure: A Case-Control StudyEdwin Kamau, Sidhartha Chaudhury, Jessica S Bolton, et al.
Plos One|October 30, 2008
Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adultsArlene E Dent, Elke S Bergmann-Leitner, Danny W Wilson, et al.
The Journal of Infectious Diseases|April 3, 2020
Multifunctional Antibodies Are Induced by the RTS,S Malaria Vaccine and Associated With Protection in a Phase 1/2a TrialLiriye Kurtovic, Tanmaya Atre, Gaoqian Feng, et al.
Vaccine|June 10, 2017
Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013Christopher J Genito, Zoltan Beck, Timothy W Phares, et al.
International Immunology|February 16, 2005
C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malariaElke S Bergmann-Leitner, Sandra Scheiblhofer, Richard Weiss, et al.
Pageof 26

Showing results (221-230 of 254) with videos related to

Sort By:
Pageof 26
Journal of Extracellular Biology|August 7, 2023
Retroviral b-Zip protein (HBZ) contributes to the release of soluble and exosomal immune checkpoint molecules in the context of neuroinflammationJulie Joseph, Thomas A Premeaux, Daniel O Pinto, et al.
Vaccine|January 12, 2021
Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS,S malaria vaccineSidhartha Chaudhury, Randall S MacGill, Angela M Early, et al.
Frontiers in Immunology|July 13, 2013
Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malariaElke S Bergmann-Leitner, Heather Hosie, Jessica Trichilo, et al.
Poultry Science|November 30, 2018
Investigation of the prevalence and severity of foot pad dermatitis at the slaughterhouse in fattening turkeys reared in organic production systems in GermanyD Freihold, T Bartels, S Bergmann, et al.
Vaccine|December 23, 2017
Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccineStephen A Kaba, Christopher P Karch, Labdhi Seth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2022
Susceptibility to Human Immunodeficiency Virus Type 1 Acquisition Linked to Malaria Exposure: A Case-Control StudyEdwin Kamau, Sidhartha Chaudhury, Jessica S Bolton, et al.
Plos One|October 30, 2008
Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adultsArlene E Dent, Elke S Bergmann-Leitner, Danny W Wilson, et al.
The Journal of Infectious Diseases|April 3, 2020
Multifunctional Antibodies Are Induced by the RTS,S Malaria Vaccine and Associated With Protection in a Phase 1/2a TrialLiriye Kurtovic, Tanmaya Atre, Gaoqian Feng, et al.
Vaccine|June 10, 2017
Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013Christopher J Genito, Zoltan Beck, Timothy W Phares, et al.
International Immunology|February 16, 2005
C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malariaElke S Bergmann-Leitner, Sandra Scheiblhofer, Richard Weiss, et al.
Pageof 26